AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
DEL PRIS
SecurityDE:4AB / AbbVie Inc.
InstitutionFoster & Motley Inc
Latest Disclosed Ownership56,317 shares
Latest Disclosed Value $ 12,248
Foster & Motley Inc reports 0.59% increase in ownership of 4AB / AbbVie Inc.

On April 21, 2026 - Foster & Motley Inc filed a 13F-HR form disclosing ownership of 56,317 shares of AbbVie Inc. (DE:4AB) valued at $10,441,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 55,989 shares of AbbVie Inc.. This represents a change in shares of 0.59% during the quarter. The current value of the position is $10,615,754 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F AbbVie com 00287Y109 56,317 328 0.59 12 0.00 0.6319
2026-01-15 2025-12-31 13F AbbVie com 00287Y109 55,989 -1,751 -3.03 13 -7.69 0.6822
2025-10-23 2025-09-30 13F AbbVie com 00287Y109 57,740 -571 -0.98 13 30.00 0.7206
2025-07-29 2025-06-30 13F AbbVie com 00287Y109 58,311 619 1.07 11 -16.67 0.6253
2025-05-08 2025-03-31 13F AbbVie com 00287Y109 57,692 -853 -1.46 12 20.00 0.7611
2025-01-23 2024-12-31 13F AbbVie com 00287Y109 58,545 900 1.56 10 -9.09 0.6766
2024-10-30 2024-09-30 13F AbbVie com 00287Y109 57,645 -3,159 -5.20 11 10.00 0.7220
2024-08-02 2024-06-30 13F AbbVie com 00287Y109 60,804 910 1.52 10 0.00 0.7167
2024-04-18 2024-03-31 13F AbbVie com 00287Y109 59,894 1,145 1.95 11 11.11 0.7508
2024-02-01 2023-12-31 13F AbbVie com 00287Y109 58,749 1,067 1.85 9 12.50 0.6763
2023-10-24 2023-09-30 13F AbbVie com 00287Y109 57,682 128 0.22 9 14.29 0.7049
2023-08-08 2023-06-30 13F AbbVie com 00287Y109 57,554 905 1.60 8 -22.22 0.6006
2023-05-09 2023-03-31 13F AbbVie com 00287Y109 56,649 1,022 1.84 9 12.50 0.7347
2023-02-09 2022-12-31 13F AbbVie com 00287Y109 55,627 -93 -0.17 9 -99.89 0.7674
2022-11-04 2022-09-30 13F AbbVie com 00287Y109 55,720 849 1.55 7,478 -11.02 0.7100
2022-08-09 2022-06-30 13F AbbVie com 00287Y109 54,871 1,386 2.59 8,404 -3.07 0.7385
2022-04-28 2022-03-31 13F AbbVie com 00287Y109 53,485 1,028 1.96 8,670 22.06 0.6798
2022-01-25 2021-12-31 13F AbbVie com 00287Y109 52,457 1,221 2.38 7,103 28.51 0.5527
2021-10-29 2021-09-30 13F AbbVie com 00287Y109 51,236 -446 -0.86 5,527 -5.05 0.4601
2021-07-20 2021-06-30 13F AbbVie com 00287Y109 51,682 5,046 10.82 5,821 15.34 0.4875
2021-04-26 2021-03-31 13F AbbVie com 00287Y109 46,636 -570 -1.21 5,047 -0.22 0.4209
2021-02-01 2020-12-31 13F AbbVie com 00287Y109 47,206 -642 -1.34 5,058 20.69 0.4886
2020-10-19 2020-09-30 13F AbbVie com 00287Y109 47,848 15 0.03 4,191 -10.75 0.4938
2020-07-20 2020-06-30 13F AbbVie com 00287Y109 47,833 1,071 2.29 4,696 31.80 0.5875
2020-04-21 2020-03-31 13F AbbVie com 00287Y109 46,762 5,223 12.57 3,563 -3.13 0.5315
2020-02-05 2019-12-31 13F AbbVie com 00287Y109 41,539 -888 -2.09 3,678 14.47 0.4607
2019-10-24 2019-09-30 13F AbbVie com 00287Y109 42,427 -1,722 -3.90 3,213 0.06 0.4378
2019-07-17 2019-06-30 13F AbbVie com 00287Y109 44,149 -1,148 -2.53 3,211 -12.03 0.4502
2019-05-08 2019-03-31 13F AbbVie com 00287Y109 45,297 -10 -0.02 3,650 -12.62 0.5261
2019-01-30 2018-12-31 13F AbbVie com 00287Y109 45,307 337 0.75 4,177 -1.79 0.6686
2018-10-31 2018-09-30 13F AbbVie com 00287Y109 44,970 909 2.06 4,253 4.19 0.6380
2018-07-24 2018-06-30 13F AbbVie com 00287Y109 44,061 3,148 7.69 4,082 5.42 0.6509
2018-05-14 2018-03-31 13F AbbVie com 00287Y109 40,913 2,358 6.12 3,872 3.83 0.6309
2018-01-22 2017-12-31 13F AbbVie com 00287Y109 38,555 -536 -1.37 3,729 7.34 0.5959
2017-10-19 2017-09-30 13F AbbVie com 00287Y109 39,091 -135 -0.34 3,474 22.15 0.5979
2017-07-31 2017-06-30 13F AbbVie com 00287Y109 39,226 -198 -0.50 2,844 10.70 0.5024
2017-04-24 2017-03-31 13F AbbVie com 00287Y109 39,424 65 0.17 2,569 4.22 0.4684
2017-01-19 2016-12-31 13F AbbVie com 00287Y109 39,359 -50 -0.13 2,465 -0.84 0.4717
2016-10-28 2016-09-30 13F AbbVie com 00287Y109 39,409 -1,100 -2.72 2,486 -0.88 0.4797
2016-08-02 2016-06-30 13F AbbVie com 00287Y109 40,509 -998 -2.40 2,508 5.78 0.4952
2016-04-20 2016-03-31 13F AbbVie com 00287Y109 41,507 9,365 29.14 2,371 24.53 0.4801
2016-01-25 2015-12-31 13F AbbVie com 00287Y109 32,142 4,345 15.63 1,904 25.93 0.4039
2015-11-09 2015-09-30 13F AbbVie com 00287Y109 27,797 -1,603 -5.45 1,512 -23.44 0.3440
2015-08-10 2015-06-30 13F AbbVie com 00287Y109 29,400 -1,948 -6.21 1,975 7.63 0.4335
2015-04-16 2015-03-31 13F AbbVie com 00287Y109 31,348 -1,678 -5.08 1,835 -15.09 0.4029
2015-01-22 2014-12-31 13F AbbVie com 00287Y109 33,026 -3,555 -9.72 2,161 2.27 0.4895
2014-10-16 2014-09-30 13F AbbVie com 00287Y109 36,581 -17,365 -32.19 2,113 -30.61 0.4906
2014-07-25 2014-06-30 13F AbbVie com 00287Y109 53,946 -11,600 -17.70 3,045 -9.62 0.7029
2014-04-23 2014-03-31 13F AbbVie com 00287Y109 65,546 -38,109 -36.77 3,369 -38.45 0.8281
2014-01-17 2013-12-31 13F AbbVie com 00287Y109 103,655 -24,771 -19.29 5,474 -4.70 1.3812
2013-10-16 2013-09-30 13F AbbVie com 00287Y109 128,426 -5,325 -3.98 5,744 3.89 1.5330
2013-07-17 2013-06-30 13F AbbVie com 00287Y109 133,751 133,751 5,529 1.5370
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.